Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2017 | 1 |
2018 | 2 |
2020 | 1 |
2021 | 3 |
2022 | 1 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Grading Evolution and Contemporary Prognostic Biomarkers of Clinically Significant Prostate Cancer.
Cancers (Basel). 2021 Feb 5;13(4):628. doi: 10.3390/cancers13040628.
Cancers (Basel). 2021.
PMID: 33562508
Free PMC article.
Review.
Infectious complications after transrectal MRI-targeted and systematic prostate biopsy.
Kalalahti I, Huotari K, Erickson AM, Petas A, Vasarainen H, Rannikko A.
Kalalahti I, et al. Among authors: erickson am.
World J Urol. 2022 Sep;40(9):2261-2265. doi: 10.1007/s00345-022-04104-1. Epub 2022 Aug 5.
World J Urol. 2022.
PMID: 35930069
Free PMC article.
Item in Clipboard
Transcript analysis of commercial prostate cancer risk stratification panels in hard-to-predict grade group 2-4 prostate cancers.
Lehto TK, Stürenberg C, Malén A, Erickson AM, Koistinen H, Mills IG, Rannikko A, Mirtti T.
Lehto TK, et al. Among authors: erickson am.
Prostate. 2021 May;81(7):368-376. doi: 10.1002/pros.24108. Epub 2021 Mar 18.
Prostate. 2021.
PMID: 33734461
Item in Clipboard
Cumulative Cancer Locations is a Novel Metric for Predicting Active Surveillance Outcomes: A Multicenter Study.
Erickson AM, Luzzago S, Semjonow A, Vasarainen H, Laajala TD, Musi G, de Cobelli O, Mirtti T, Rannikko A.
Erickson AM, et al.
Eur Urol Oncol. 2018 Sep;1(4):268-275. doi: 10.1016/j.euo.2018.04.006. Epub 2018 May 15.
Eur Urol Oncol. 2018.
PMID: 31100247
Item in Clipboard
PTEN and ERG expression in MRI-ultrasound guided fusion biopsy correlated with radical prostatectomy findings in men with prostate cancer.
Erickson AM, Lokman U, Lahdensuo K, Tornberg S, Visapaa H, Bergroth R, Santti H, Petas A, Rannikko AS, Mirtti T.
Erickson AM, et al.
Prostate. 2020 Sep;80(13):1118-1127. doi: 10.1002/pros.24040. Epub 2020 Jul 7.
Prostate. 2020.
PMID: 32634262
Item in Clipboard
Does Protocol Make a Difference? Comparison of Two Prostate Cancer Active Surveillance Cohorts: A Non-protocol-based Follow-up and a Protocol-based Contemporary Follow-up.
Kalalahti I, Vasarainen H, Erickson AM, Siipola A, Tikkinen KAO, Rannikko A.
Kalalahti I, et al. Among authors: erickson am.
Eur Urol Open Sci. 2021 Oct 28;34:33-40. doi: 10.1016/j.euros.2021.09.016. eCollection 2021 Dec.
Eur Urol Open Sci. 2021.
PMID: 34934965
Free PMC article.
Item in Clipboard
PTEN Loss but Not ERG Expression in Diagnostic Biopsies Is Associated with Increased Risk of Progression and Adverse Surgical Findings in Men with Prostate Cancer on Active Surveillance.
Lokman U, Erickson AM, Vasarainen H, Rannikko AS, Mirtti T.
Lokman U, et al. Among authors: erickson am.
Eur Urol Focus. 2018 Dec;4(6):867-873. doi: 10.1016/j.euf.2017.03.004. Epub 2017 Mar 22.
Eur Urol Focus. 2018.
PMID: 28753869
Free article.
Item in Clipboard
Cite
Cite